|
|
| BioFlash |
In Partnership With MassBio |
|
 |
| | An ally—for every stage from inspiration to success. In the trenches, you need more than a partner. You need an ally. Someone who can foresee the pitfalls. Someone who’s been there before. That’s Pepper Hamilton. We’re an ally for clients in biotechnology, pharmaceuticals, medical devices, life sciences and health care. From raising capital, to protecting intellectual property, to deals of every size, to bet-the-company litigation, count on Pepper Hamilton. | | | |
|
|
|
|
|
Proposed Employment Law Would Create New Protected Class: The Unemployed
Bills recently introduced in both the U.S. House and Senate would make it illegal for employers and employment agencies to screen out unemployed job seekers. Like other employment laws, the proposed legislation is well-intentioned. However, it would significantly affect how businesses evaluate job candidates and would create a new source of legal claims. For a full explanation of the proposed law, see MBBP's Good Company blog.
For more information on this legislation, please contact Bob Shea.
|
|
|
|
|
|
VBI acquires French vaccine developer Epixis
|
VBI Vaccines, a Cambridge vaccine developer that quietly changed its name from Variation Biotechnologies Inc. in recent months, has acquired French biotech firm Epixis SA for an undisclosed amount.
> Read more of this article | > Back to the top
|
|
|
With a new software platform, the UNIFI Scientific Information System, that uniquely combines chromatography and mass spectrometry techniques, Waters comprehensively unites UPLC/MS analyses and workflows. The Waters Biopharmaceutical System Solution with UNIFI captures all characterization data necessary to achieve business goals for GxP biopharmaceutical laboratories, while meeting the converging needs of analytical researchers, compliance activities, and IT departments, by enabling data sharing throughout a global biopharmaceutical organization. Learn more at www.waters.com/biopharm
|
|
|
|
|
|
Langer wins prestigious Alpert Prize
|
Bob Langer, MIT chemical engineering professor and prolific life sciences startup creator, has been tapped to share the 2011 Warren Alpert Foundation Prize with cardiac surgeon Alain F. Carpentier of Paris.
> Read more of this article | > Back to the top
|
|
|
Need a flexible, scalable team to meet your custom bioinformatics and cheminformatics requirements?
GGA Software Services offers world-class scientific informatics capabilities, combining science, mathematics, and software engineering to solve informatics problems for life sciences companies. We develop, maintain, and test best-of-class applications, algorithms, and content databases, as well as provide ongoing support, maintenance, and QA services, delivering high quality solutions in cost-effective ways.
Learn more: Jim Martin, Director, Market Development - (617) 491-5100 x224; www.ggasoftware.com.
|
|
|
|
|
|
GE, VC firms launch innovation challenge to fight cancer
|
GE and venture capital firms Kleiner Perkins Caufield & Byers, Venrock, Mohr Davidow and MPM Capital have launched a $100 million healthymagination open innovation challenge aimed at funding promising initiatives that may improve breast cancer diagnostics.
> Read more of this article | > Back to the top
|
|
|
Innovation All-Stars
Mass High Tech & The Boston Business Journal are joining forces to create a powerful new event in 2011. Capitalizing on 16 years of selecting High Tech All-Stars, combined with the region’s most promising rising stars under the age of 30… Innovation All-Stars will become the pre-eminent event where promises meets performance. 15 individuals will be honored as tech luminaries and 15 individuals will be honored as rising stars.
CLICK HERE for more event details and to register
November 16, 2011, 6:00pm - 9:00pm
House of Blues, Boston
|
|
|
|
|
|
M2D2 set to open renovated med device incubator space in Lowell
|
The University of Massachusetts Lowell is planning an official opening of its renovated medical device business incubator, the Massachusetts Medical Device Development Center (M2D2) on Sept. 22.
> Read more of this article | > Back to the top
|
|
|
Mass High Tech is the No. 1 trusted source for technology business news in
New England. Now access our reporting for free on your mobile phone! Our new app includes:
• Latest News
• News by Industry
• Local Business Events Listing
• Access to Exclusive Print Edition Articles
Mass High Tech is your one-stop source for New England technology news — in print, online and mobile.
MHT’s mobile app is sponsored by Foley Hoag.
|
|
|
|
|
|
NABsys nabs $10M in VC financing round
|
DNA sequencing firm NABsys Inc., of Providence, R.I., has completed a $10 million round of venture capital financing, led by Stata Venture Partners.
> Read more of this article | > Back to the top
|
|
|
Tech Pulse Poll: How is the fall event season shaping up for you?
|
Fall event season is upon us. Networking nights, panel discussions, unconferences and training sessions are filling online calendars. How is the fall event season shaping up for you?
> Read more of this article | > Back to the top
|
|
|
| |
Innovators’ Roundtable: Infectious Disease
October 18th, 2011
AstraZeneca, 35 Gatehouse Lane, Waltham
While the 20th Century will be credited for eradication or management of many of the world’s most devastating transmissible diseases - like Measles, Polio, Ricketts, and AIDS - the 21st Century may well be known for its neglect for failing to control infectious disease. Globalization, on all fronts, is creating the environment for re-emergence of transmissible disease, yet the industry is poorly poised to handle the management of this resurgence.
Join us for an Innovators’ Roundtable, which will convene various stakeholders in health care delivery to see how downstream changes can improve upstream finance and development challenges in infectious disease. Regulators (what gets approved), reimbursement (what will get paid for), and hospitals (what will get administered) all play a critical role in the delivery of healthcare. This forum will look at how each sector views innovative new drugs vis-à-vis standard of care especially in the face of re-emergent disease and managing healthcare costs.
For more information or to register, visit http://www.massbio.org/events/calendar/1298-innovators_roundtable_infectious_disease/event_detail.
|
|
| |
|
|
|
icon indicate news first reported in the print edition.
